🇺🇸 FDA

Company profile · Sponsor

Zhongshan

Zhongshan Ophthalmic Center, Sun Yat-sen University

C46FFD7 · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Zhongshan (C46FFD7) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C46FFD7
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. 0.1% bromfenac

    Zhongshan

    Pterygium

    approved small molecule completed

    1 trial

  2. Routine IOP-lowering medications

    Zhongshan

    Open Angle Glaucoma

    small molecule active

    1 trial

Frequently asked questions

What is Zhongshan?

Zhongshan (C46FFD7) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Zhongshan sponsor?

We track 2 ClinicalTrials.gov-linked programs for Zhongshan, including 0.1% bromfenac and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Zhongshan company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.